Quality of Life Measures

  • Christopher B. AndersonEmail author
  • David F. Penson
  • Daniel A. Barocas


Although objective survival endpoints are important, they may not fully capture the impact of treatment for bladder cancer. Health-related quality of life (HRQOL) is a subjective, patient-centric outcome that provides a more complete assessment of the impact of a disease or its treatment. HRQOL is a vital component when counseling and treating bladder cancer patients, and is also an important comparative-effectiveness research outcome. Although there is no gold-standard method for measuring HRQOL in bladder cancer, the use of reliable, valid and responsive disease-specific instruments is mandatory. Studies to date have not consistently demonstrated the superiority of any diversion type after radical cystectomy, however with proper patient selection and preoperative counseling, postoperative HRQOL can be comparable between diversions. With ongoing study of HRQOL in bladder cancer, we will continue to improve cancer survivorship and refine patient treatment.


Health-related quality of life Bladder cancer Instrument Urinary diversion Treatment outcome 


  1. 1.
    Greer S. The psychological dimension in cancer treatment. Soc Sci Med. 1984;18(4):345–9. Epub 1984/01/01.PubMedGoogle Scholar
  2. 2.
    Tannock IF. Management of breast and prostate cancer: how does quality of life enter the equation? Oncology (Williston Park). 1990;4(5):149–56. discussion 71. Epub 1990/05/01.Google Scholar
  3. 3.
    Burns L, Chase D, Goodwin Jr WJ. Treatment of patients with stage IV cancer: do the ends justify the means? Otolaryngol Head Neck Surg. 1987;97(1):8–14.PubMedGoogle Scholar
  4. 4.
    Izsak FC, Medalie JH. Comprehensive follow-up of carcinoma patients. J Chronic Dis. 1971;24(2):179–91. Epub 1971/07/01.PubMedGoogle Scholar
  5. 5.
    Ware Jr JE. Methodology in behavioral and psychosocial cancer research. Conceptualizing disease impact and treatment outcomes. Cancer. 1984;53(10 Suppl):2316–26. Epub 1984/05/15.PubMedGoogle Scholar
  6. 6.
    Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. J Clin Oncol. 1996;14(2):671–9. Epub 1996/02/01Google Scholar
  7. 7.
    Lee CT. Quality of life following incontinent cutaneous and orthotopic urinary diversions. Curr Treat Options Oncol. 2009;10(3–4):275–86. Epub 2009/09/19.PubMedGoogle Scholar
  8. 8.
    Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164–74. Epub 2008/08/05.PubMedGoogle Scholar
  9. 9.
    Whitmore Jr WF, Marshall VF. Radical total cystectomy for cancer of the bladder: 230 consecutive cases five years later. J Urol. 1962;87:853–68. Epub 1962/06/01.PubMedGoogle Scholar
  10. 10.
    Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19(3):666–75. Epub 2001/02/07.PubMedGoogle Scholar
  11. 11.
    CONSTITUTION of the World Health Organization. Chron World Health Organ. 1947;1(1–2):29–43. Epub 1947/01/01.Google Scholar
  12. 12.
    Cella DF, Tulsky DS. Quality of life in cancer: definition, purpose, and method of measurement. Cancer Invest. 1993;11(3):327–36. Epub 1993/01/01.PubMedGoogle Scholar
  13. 13.
    Aaronson NK, Calais da Silva F, Yoshida O, van Dam FS, Fossa SD, Miyakawa M, et al. Quality of life assessment in bladder cancer clinical trials: conceptual, methodological and practical issues. Prog Clin Biol Res. 1986;221:149–70. Epub 1986/01/01.PubMedGoogle Scholar
  14. 14.
    Calman KC. Quality of life in cancer patients—an hypothesis. J Med Ethics. 1984;10(3):124–7. Epub 1984/09/01.PubMedCentralPubMedGoogle Scholar
  15. 15.
    Weymuller E, Deleyiannis FW-B, Yueh B. Quality of life in patients with head and neck cancer. In: Meyers E, Suen J, Meyers J, EYN H, editors. Cancer of the head and neck. 4th ed. Philadelphia: Saunders; 2003.Google Scholar
  16. 16.
    Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42. Epub 2010/09/08.PubMedGoogle Scholar
  17. 17.
    Lule D, Zickler C, Hacker S, Bruno MA, Demertzi A, Pellas F, et al. Life can be worth living in locked-in syndrome. Prog Brain Res. 2009;177:339–51. Epub 2009/10/13.PubMedGoogle Scholar
  18. 18.
    Postulart D, Adang EM. Response shift and adaptation in chronically ill patients. Med Decis Making. 2000;20(2):186–93. Epub 2000/04/20.PubMedGoogle Scholar
  19. 19.
    van der Veen JH, van Andel G, Kurth KH. Quality-of-life assessment in bladder cancer. World J Urol. 1999;17(4):219–24. Epub 1999/08/25.PubMedGoogle Scholar
  20. 20.
    D’Angelica M, Hirsch K, Ross H, Passik S, Brennan MF. Surgeon-patient communication in the treatment of pancreatic cancer. Arch Surg. 1998;133(9):962–6. Epub 1998/09/28.PubMedGoogle Scholar
  21. 21.
    Fallowfield L. The quality of life: the missing measurement in health care. London: Souvenir Press; 1990.Google Scholar
  22. 22.
    Fallowfield LJ, Baum M, Maguire GP. Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J (Clin Res Ed). 1986;293(6558):1331–4. Epub 1986/11/22.Google Scholar
  23. 23.
    Buck D, Jacoby A. Health outcomes and quality of life. In: Dyck P, editor. Peripheral neuropathy. 4th ed. Philadelphia: Elsevier; 2005.Google Scholar
  24. 24.
    Evans B, Montie JE, Gilbert SM. Incontinent or continent urinary diversion: how to make the right choice. Curr Opin Urol. 2010;20(5):421–5. Epub 2010/07/10.PubMedGoogle Scholar
  25. 25.
    Mitchell AJ, Chan M, Bhatti H, Halton M, Grassi L, Johansen C, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol. 2011;12(2):160–74. Epub 2011/01/22.PubMedGoogle Scholar
  26. 26.
    Werner A, Stenner C, Schuz J. Patient versus clinician symptom reporting: how accurate is the detection of distress in the oncologic after-care? Psychooncology. 2011. Epub 2011/05/06Google Scholar
  27. 27.
    Fobair P, Hoppe RT, Bloom J, Cox R, Varghese A, Spiegel D. Psychosocial problems among survivors of Hodgkin’s disease. J Clin Oncol. 1986;4(5):805–14. Epub 1986/05/01.PubMedGoogle Scholar
  28. 28.
    Litwin MS, Hays RD, Fink A, Ganz PA, Leake B, Brook RH. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36(7):1002–12. Epub 1998/07/23.PubMedGoogle Scholar
  29. 29.
    Church J. Outcomes analysis and measurement of quality of life. In: Fazio V, Church J, Delaney C, editors. Current therapy in colon and rectal surgery. 2nd ed. Elsevier Mosby: Philadelphia; 2005.Google Scholar
  30. 30.
    de Graeff A, de Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Sociodemographic factors and quality of life as prognostic indicators in head and neck cancer. Eur J Cancer. 2001;37(3):332–9. Epub 2001/03/10.PubMedGoogle Scholar
  31. 31.
    Pompili C, Salati M, Refai M, Berardi R, Onofri A, Mazzanti P, et al. Preoperative quality of life predicts survival following pulmonary resection in stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2012;43(5):905–10.PubMedGoogle Scholar
  32. 32.
    Palapattu GS, Bastian PJ, Slavney PR, Haisfield-Wolfe ME, Walker JM, Brintzenhofeszoc K, et al. Preoperative somatic symptoms are associated with disease progression in patients with bladder carcinoma after cystectomy. Cancer. 2004;101(10):2209–13. Epub 2004/10/12.PubMedGoogle Scholar
  33. 33.
    Mansson A, Christensson P, Johnson G, Colleen S. Can preoperative psychological defensive strategies, mood and type of lower urinary tract reconstruction predict psychosocial adjustment after cystectomy in patients with bladder cancer? Br J Urol. 1998;82(3):348–56. Epub 1998/10/17.PubMedGoogle Scholar
  34. 34.
    Burris 3rd HA, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol. 1997;15(6):2403–13. Epub 1997/06/01.PubMedGoogle Scholar
  35. 35.
    Moore MJ, Osoba D, Murphy K, Tannock IF, Armitage A, Findlay B, et al. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer. J Clin Oncol. 1994;12(4):689–94. Epub 1994/04/01.PubMedGoogle Scholar
  36. 36.
    Whalen GF, Ferrans CE. Quality of life as an outcome in clinical trials and cancer care: a primer for surgeons. J Surg Oncol. 2001;77(4):270–6. Epub 2001/07/27.PubMedGoogle Scholar
  37. 37.
    EORTC Quality of Life. Available from: Accessed 21 Apr 2013.
  38. 38.
    Patient-Centered Outcomes Research Institute. Available from: Accessed 21 Apr 2013.
  39. 39.
    Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44(3 Suppl):166–206. Epub 1966/07/01.PubMedGoogle Scholar
  40. 40.
    Sheldon A, Ryser CP, Krant MJ. An integrated family orientated cancer care program: the report of a pilot project in the socio-emotional management of chronic disease. J Chronic Dis. 1970;22(11):743–55. Epub 1970/04/01.PubMedGoogle Scholar
  41. 41.
    Hadorn DC. Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue. JAMA. 1991;265(17):2218–25. Epub 1991/05/01.PubMedGoogle Scholar
  42. 42.
    O’Young J, McPeek B. Quality of life variables in surgical trials. J Chronic Dis. 1987;40(6):513–22. Epub 1987/01/01.PubMedGoogle Scholar
  43. 43.
    Abbona A, Morabito F, Rossi R, Billia M, Liberale F, Ferrando U. Quality of life in patients undergone oncopreventive intravesical treatment for superficial bladder cancer. Arch Ital Urol Androl. 2007;79(4):143–6. Epub 2008/02/29.PubMedGoogle Scholar
  44. 44.
    Mack D, Frick J. Quality of life in patients undergoing bacille Calmette-Guerin therapy for superficial bladder cancer. Br J Urol. 1996;78(3):369–71. Epub 1996/09/01.PubMedGoogle Scholar
  45. 45.
    Muezzinoglu T, Ceylan Y, Temeltas G, Lekili M, Buyuksu C. Evaluation of pain caused by urethrocystoscopy in patients with superficial bladder cancer: a perspective of quality of life. Onkologie. 2005;28(5):260–4. Epub 2005/05/04.PubMedGoogle Scholar
  46. 46.
    Yoshimura K, Utsunomiya N, Ichioka K, Matsui Y, Terai A, Arai Y. Impact of superficial bladder cancer and transurethral resection on general health-related quality of life: an SF-36 survey. Urology. 2005;65(2):290–4. Epub 2005/02/15.PubMedGoogle Scholar
  47. 47.
    Gerharz EW, Mansson A, Hunt S, Skinner EC, Mansson W. Quality of life after cystectomy and urinary diversion: an evidence based analysis. J Urol. 2005;174(5):1729–36. Epub 2005/10/12.PubMedGoogle Scholar
  48. 48.
    Hautmann RE, de Petriconi RC, Volkmer BG. 25 years of experience with 1,000 neobladders: long-term complications. J Urol. 2011;185(6):2207–12. Epub 2011/04/19.PubMedGoogle Scholar
  49. 49.
    Hedgepeth RC, Gilbert SM, He C, Lee CT, Wood Jr DP. Body image and bladder cancer specific quality of life in patients with ileal conduit and neobladder urinary diversions. Urology. 2010;76(3):671–5. Epub 2010/05/11.PubMedGoogle Scholar
  50. 50.
    Palapattu GS, Haisfield-Wolfe ME, Walker JM, BrintzenhofeSzoc K, Trock B, Zabora J, et al. Assessment of perioperative psychological distress in patients undergoing radical cystectomy for bladder cancer. J Urol. 2004;172(5 Pt 1):1814–7. Epub 2004/11/16.PubMedGoogle Scholar
  51. 51.
    Shimko MS, Tollefson MK, Umbreit EC, Farmer SA, Blute ML, Frank I. Long-term complications of conduit urinary diversion. J Urol. 2011;185(2):562–7. Epub 2010/12/21.PubMedGoogle Scholar
  52. 52.
    Blanchard CM, Courneya KS, Stein K. Cancer survivors’ adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society’s SCS-II. J Clin Oncol. 2008;26(13):2198–204. Epub 2008/05/01.PubMedGoogle Scholar
  53. 53.
    Karvinen KH, Courneya KS, North S, Venner P. Associations between exercise and quality of life in bladder cancer survivors: a population-based study. Cancer Epidemiol Biomarkers Prev. 2007;16(5):984–90. Epub 2007/05/18.PubMedGoogle Scholar
  54. 54.
    Cody JD, Nabi G, Dublin N, McClinton S, Neal DE, Pickard R, et al. Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev. 2012;2, CD003306. Epub 2012/02/18.PubMedGoogle Scholar
  55. 55.
    Porter MP, Penson DF. Health related quality of life after radical cystectomy and urinary diversion for bladder cancer: a systematic review and critical analysis of the literature. J Urol. 2005;173(4):1318–22. Epub 2005/03/11.PubMedGoogle Scholar
  56. 56.
    Wright JL, Porter MP. Quality-of-life assessment in patients with bladder cancer. Nat Clin Pract Urol. 2007;4(3):147–54. Epub 2007/03/10.PubMedGoogle Scholar
  57. 57.
    Allareddy V, Kennedy J, West MM, Konety BR. Quality of life in long-term survivors of bladder cancer. Cancer. 2006;106(11):2355–62. Epub 2006/05/02.PubMedGoogle Scholar
  58. 58.
    Visser MR, Oort FJ, van Lanschot JJ, van der Velden J, Kloek JJ, Gouma DJ, et al. The role of recalibration response shift in explaining bodily pain in cancer patients undergoing invasive surgery: an empirical investigation of the Sprangers and Schwartz model. Psychooncology. 2013;22(3):515–22. Epub 2012/01/17.PubMedGoogle Scholar
  59. 59.
    Brickman P, Coates D, Janoff-Bulman R. Lottery winners and accident victims: is happiness relative? J Pers Soc Psychol. 1978;36(8):917–27. Epub 1978/08/01.PubMedGoogle Scholar
  60. 60.
    McGuire MS, Grimaldi G, Grotas J, Russo P. The type of urinary diversion after radical cystectomy significantly impacts on the patient’s quality of life. Ann Surg Oncol. 2000;7(1):4–8. Epub 2000/02/16.PubMedGoogle Scholar
  61. 61.
    Adang EM, Kootstra G, Engel GL, van Hooff JP, Merckelbach HL. Do retrospective and prospective quality of life assessments differ for pancreas-kidney transplant recipients? Transpl Int. 1998;11(1):11–5. Epub 1998/03/21.PubMedGoogle Scholar
  62. 62.
    Adang EM, Kootstra G, Baeten CG, Engel GL. Quality-of-life ratings in patients with chronic illnesses. JAMA. 1997;277(13):1038. Epub 1997/04/02.PubMedGoogle Scholar
  63. 63.
    Aaronson NK. Quality of life assessment in clinical trials: methodologic issues. Control Clin Trials. 1989;10(4 Suppl):195S–208. Epub 1989/12/01.PubMedGoogle Scholar
  64. 64.
    Karnofsky DA, Burchenal J. The clinical evaluation of chemotheraputic agents in cancer. In: MacLeod C, editor. Evaluation of chemotheraputic agents. New York: Colombia University Press; 1949. p. 196.Google Scholar
  65. 65.
    Hutchinson TA, Boyd NF, Feinstein AR, Gonda A, Hollomby D, Rowat B. Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis. 1979;32(9–10):661–6. Epub 1979/01/01.PubMedGoogle Scholar
  66. 66.
    Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: reliability, validity, and guidelines. J Clin Oncol. 1984;2(3):187–93. Epub 1984/03/01.PubMedGoogle Scholar
  67. 67.
    Slevin ML, Plant H, Lynch D, Drinkwater J, Gregory WM. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988;57(1):109–12. Epub 1988/01/01.PubMedCentralPubMedGoogle Scholar
  68. 68.
    Dinglas VD, Gifford JM, Husain N, Colantuoni E, Needham DM. Quality of life before intensive care using EQ-5D: patient versus proxy responses. Crit Care Med. 2013;41(1):9–14. Epub 2012/12/13.PubMedCentralPubMedGoogle Scholar
  69. 69.
    Vickery CW, Blazeby JM, Conroy T, Arraras J, Sezer O, Koller M, et al. Development of an EORTC disease-specific quality of life module for use in patients with gastric cancer. Eur J Cancer. 2001;37(8):966–71. Epub 2001/05/04.PubMedGoogle Scholar
  70. 70.
    Paasche-Orlow MK, Taylor HA, Brancati FL. Readability standards for informed-consent forms as compared with actual readability. N Engl J Med. 2003;348(8):721–6. Epub 2003/02/21.PubMedGoogle Scholar
  71. 71.
    Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42. Epub 2006/12/13.PubMedGoogle Scholar
  72. 72.
    Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272(8):619–26. Epub 1994/08/24.PubMedGoogle Scholar
  73. 73.
    Parkinson JP, Konety BR. Health related quality of life assessments for patients with bladder cancer. J Urol. 2004;172(6 Pt 1):2130–6. Epub 2004/11/13.PubMedGoogle Scholar
  74. 74.
    Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care. 2003;41(5):582–92. Epub 2003/04/30.PubMedGoogle Scholar
  75. 75.
    Kulaksizoglu H, Toktas G, Kulaksizoglu IB, Aglamis E, Unluer E. When should quality of life be measured after radical cystectomy? Eur Urol. 2002;42(4):350–5. Epub 2002/10/04.PubMedGoogle Scholar
  76. 76.
    Guyatt GH, Naylor CD, Juniper E, Heyland DK, Jaeschke R, Cook DJ. Users’ guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group. JAMA. 1997;277(15):1232–7. Epub 1997/04/16.PubMedGoogle Scholar
  77. 77.
    Bergner M, Bobbitt RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805. Epub 1981/08/01.PubMedGoogle Scholar
  78. 78.
    Hunt SM, McEwen J, McKenna SP. Measuring health status: a new tool for clinicians and epidemiologists. J R Coll Gen Pract. 1985;35(273):185–8. Epub 1985/04/01.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Ware Jr JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83. Epub 1992/06/11.PubMedGoogle Scholar
  80. 80.
    Dutta SC, Chang SC, Coffey CS, Smith Jr JA, Jack G, Cookson MS. Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder. J Urol. 2002;168(1):164–7. Epub 2002/06/07.PubMedGoogle Scholar
  81. 81.
    Harano M, Eto M, Nakamura M, Hasegawa Y, Kano M, Yamaguchi A, et al. A pilot study of the assessment of the quality of life, functional results, and complications in patients with an ileal neobladder for invasive bladder cancer. Int J Urol. 2007;14(2):112–7. Epub 2007/02/17.PubMedGoogle Scholar
  82. 82.
    Hara I, Miyake H, Hara S, Gotoh A, Nakamura I, Okada H, et al. Health-related quality of life after radical cystectomy for bladder cancer: a comparison of ileal conduit and orthotopic bladder replacement. BJU Int. 2002;89(1):10–3. Epub 2002/02/19.PubMedGoogle Scholar
  83. 83.
    Autorino R, Quarto G, Di Lorenzo G, De Sio M, Perdona S, Giannarini G, et al. Health related quality of life after radical cystectomy: comparison of ileal conduit to continent orthotopic neobladder. Eur J Surg Oncol. 2009;35(8):858–64. Epub 2008/10/01.PubMedGoogle Scholar
  84. 84.
    Quality Metric. Available from: Accessed 21 Apr 2013.
  85. 85.
    Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11(3):570–9. Epub 1993/03/01.PubMedGoogle Scholar
  86. 86.
    Kikuchi E, Horiguchi Y, Nakashima J, Ohigashi T, Oya M, Nakagawa K, et al. Assessment of long-term quality of life using the FACT-BL questionnaire in patients with an ileal conduit, continent reservoir, or orthotopic neobladder. Jpn J Clin Oncol. 2006;36(11):712–6. Epub 2006/10/05.PubMedGoogle Scholar
  87. 87.
    Mansson A, Al Amin M, Malmstrom PU, Wijkstrom H, Abol Enein H, Mansson W. Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution—a prospective comparative study. Urology. 2007;70(6):1086–90. Epub 2007/12/26.PubMedGoogle Scholar
  88. 88.
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76. Epub 1993/03/03.PubMedGoogle Scholar
  89. 89.
    Sogni F, Brausi M, Frea B, Martinengo C, Faggiano F, Tizzani A, et al. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology. 2008;71(5):919–23. Epub 2008/03/22.PubMedGoogle Scholar
  90. 90.
    Hobisch A, Tosun K, Kinzl J, Kemmler G, Bartsch G, Holtl L, et al. Quality of life after cystectomy and orthotopic neobladder versus ileal conduit urinary diversion. World J Urol. 2000;18(5):338–44. Epub 2000/12/29.PubMedGoogle Scholar
  91. 91.
    Anderson CB, Feurer ID, Large MC, Steinberg GD, Barocas DA, Cookson MS, et al. Psychometric characteristics of a condition-specific, health-related quality-of-life survey: the FACT-Vanderbilt Cystectomy Index. Urology. 2012;80(1):77–83. Epub 2012/05/23.PubMedGoogle Scholar
  92. 92.
    Gilbert SM, Dunn RL, Hollenbeck BK, Montie JE, Lee CT, Wood DP, et al. Development and validation of the Bladder Cancer Index: a comprehensive, disease specific measure of health related quality of life in patients with localized bladder cancer. J Urol. 2010;183(5):1764–9. Epub 2010/03/20.PubMedGoogle Scholar
  93. 93.
    Bjerre BD, Johansen C, Steven K. Health-related quality of life after cystectomy: bladder substitution compared with ileal conduit diversion. A questionnaire survey. Br J Urol. 1995;75(2):200–5. Epub 1995/02/01.PubMedGoogle Scholar
  94. 94.
    Protogerou V, Moschou M, Antoniou N, Varkarakis J, Bamias A, Deliveliotis C. Modified S-pouch neobladder vs ileal conduit and a matched control population: a quality-of-life survey. BJU Int. 2004;94(3):350–4. Epub 2004/08/05.PubMedGoogle Scholar
  95. 95.
    Somani BK, Gimlin D, Fayers P, N’Dow J. Quality of life and body image for bladder cancer patients undergoing radical cystectomy and urinary diversion—a prospective cohort study with a systematic review of literature. Urology. 2009;74(5):1138–43. Epub 2009/09/24.PubMedGoogle Scholar
  96. 96.
    Cookson MS, Dutta SC, Chang SS, Clark T, Smith Jr JA, Wells N. Health related quality of life in patients treated with radical cystectomy and urinary diversion for urothelial carcinoma of the bladder: development and validation of a new disease specific questionnaire. J Urol. 2003;170(5):1926–30. Epub 2003/10/09.PubMedGoogle Scholar
  97. 97.
    Large MC, Katz MH, Shikanov S, Eggener SE, Steinberg GD. Orthotopic neobladder versus Indiana pouch in women: a comparison of health related quality of life outcomes. J Urol. 2010;183(1):201–6. Epub 2009/11/17.PubMedGoogle Scholar
  98. 98.
    Vakalopoulos I, Dimitriadis G, Anastasiadis A, Gkotsos G, Radopoulos D. Does intubated uretero-ureterocutaneostomy provide better health-related quality of life than orthotopic neobladder in patients after radical cystectomy for invasive bladder cancer? Int Urol Nephrol. 2011;43(3):743–8. Epub 2011/02/22.PubMedGoogle Scholar
  99. 99.
    Parekh DJ, Messer J, Fitzgerald J, Ercole B, Svatek R. Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol. 2013;189(2):474–9. Epub 2012/09/29.PubMedGoogle Scholar
  100. 100.
    Gilbert SM, Wood DP, Dunn RL, Weizer AZ, Lee CT, Montie JE, et al. Measuring health-related quality of life outcomes in bladder cancer patients using the Bladder Cancer Index (BCI). Cancer. 2007;109(9):1756–62. Epub 2007/03/17.PubMedGoogle Scholar
  101. 101.
    FACT-BL. Available from: Accessed 10 Mar 2013.
  102. 102.
    Mansson A, Davidsson T, Hunt S, Mansson W. The quality of life in men after radical cystectomy with a continent cutaneous diversion or orthotopic bladder substitution: is there a difference? BJU Int. 2002;90(4):386–90. Epub 2002/08/15.PubMedGoogle Scholar
  103. 103.
    Yuh B, Butt Z, Fazili A, Piacente P, Tan W, Wilding G, et al. Short-term quality-of-life assessed after robot-assisted radical cystectomy: a prospective analysis. BJU Int. 2009;103(6):800–4. Epub 2008/11/22.PubMedGoogle Scholar
  104. 104.
    Pavone-Macaluso M, Corselli G, Ingargiola GB, Serretta V. The Urologic Cooperative Group of the EORTC. Structure, scope, research, results. Arch Ital Urol Androl. 1997;69(4):209–15. Epub 1998/01/07. Il gruppo cooperativo urologico dell’EORTC. Struttura, scopi, ricerche, risultati.PubMedGoogle Scholar
  105. 105.
    EORTC QLQ-BLM-30. Available from: Accessed 10 Mar 2013.
  106. 106.
    EORTC QLQ-BLS-24. Available from: Accessed 10 Mar 2013.
  107. 107.
    Kaplan RM. Quality of life assessment for cost/utility studies in cancer. Cancer Treat Rev. 1993;19 Suppl A:85–96. Epub 1993/01/01.PubMedGoogle Scholar
  108. 108.
    Brooks R. EuroQol: the current state of play. Health Policy. 1996;37(1):53–72. Epub 1996/06/06.PubMedGoogle Scholar
  109. 109.
    Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271–92. Epub 2002/04/10.PubMedGoogle Scholar
  110. 110.
    Furlong WJ, Feeny DH, Torrance GW, Barr RD. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33(5):375–84. Epub 2001/08/09.PubMedGoogle Scholar
  111. 111.
    Andresen EM, Rothenberg BM, Kaplan RM. Performance of a self-administered mailed version of the Quality of Well-Being (QWB-SA) questionnaire among older adults. Med Care. 1998;36(9):1349–60. Epub 1998/09/28.PubMedGoogle Scholar
  112. 112.
    Somani B, MacLennan S, N’Dow J. Quality of life with urinary diversion. Eur Urol Suppl. 2010;9(10):763–71.Google Scholar
  113. 113.
    Hautmann RE, Abol-Enein H, Hafez K, Haro I, Mansson W, Mills RD, et al. Urinary diversion. Urology. 2007;69(1 Suppl):17–49. Epub 2007/02/07.PubMedGoogle Scholar
  114. 114.
    Hardt J, Filipas D, Hohenfellner R, Egle UT. Quality of life in patients with bladder carcinoma after cystectomy: first results of a prospective study. Qual Life Res. 2000;9(1):1–12. Epub 2000/09/12.PubMedGoogle Scholar
  115. 115.
    Anderson CB, Cookson MS, Chang SS, Clark PE, Smith Jr JA, Kaufman MR. Voiding function in women with orthotopic neobladder urinary diversion. J Urol. 2012;188(1):200–4. Epub 2012/05/18.PubMedGoogle Scholar
  116. 116.
    Ahmadi H, Skinner EC, Simma-Chiang V, Miranda G, Cai J, Penson DF, et al. Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. J Urol. 2013;189(5):1782–8. Epub 2012/11/20.PubMedGoogle Scholar
  117. 117.
    Zippe CD, Raina R, Shah AD, Massanyi EZ, Agarwal A, Ulchaker J, et al. Female sexual dysfunction after radical cystectomy: a new outcome measure. Urology. 2004;63(6):1153–7. Epub 2004/06/09.PubMedGoogle Scholar
  118. 118.
    Zippe CD, Raina R, Massanyi EZ, Agarwal A, Jones JS, Ulchaker J, et al. Sexual function after male radical cystectomy in a sexually active population. Urology. 2004;64(4):682–5. discussion 5–6. Epub 2004/10/20.PubMedGoogle Scholar
  119. 119.
    Orvieto MA, DeCastro GJ, Trinh QD, Jeldres C, Katz MH, Patel VR, et al. Oncological and functional outcomes after robot-assisted radical cystectomy: critical review of current status. Urology. 2011;78(5):977–84. Epub 2011/09/06.PubMedGoogle Scholar
  120. 120.
    Stegemann A, Rehman S, Brewer K, Kesavadas T, Hussain A, Chandrasekhar R, et al. Short-term patient-reported quality of life after robot-assisted radical cystectomy using the Convalescence and Recovery Evaluation. Urology. 2012;79(6):1274–9. Epub 2012/04/24.PubMedGoogle Scholar
  121. 121.
    Tallman C, Aboumohamed A, Weizer AZ, Dailey S, Khan A, Din R, et al. Health related quality of life outcomes after robotic-assisted and open radical cystectomy: a Multi-Institutional Study. American Urological Association Annual Meeting 2013, Abstract #1625.Google Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Christopher B. Anderson
    • 1
    • 2
    Email author
  • David F. Penson
    • 3
  • Daniel A. Barocas
    • 4
  1. 1.Department of Surgery, Urology ServiceMemorial Sloan Kettering Cancer CenterNew YorkUSA
  2. 2.Department of Urologic SurgeryVanderbilt University Medical CenterNashvilleUSA
  3. 3.Department of Urologic Surgery, Center for Surgical Quality and Outcomes ResearchVanderbilt University Medical CenterNashvilleUSA
  4. 4.Department of Urologic Surgery, Center for Surgical Quality and Outcomes ResearchVanderbilt University Medical CenterNashvilleUSA

Personalised recommendations